Who
Rochelle B. Lazarus
Director
Company insider
Files Form 4 as: Director, Organon & Co; Director, Blackstone; Director, Merck & Company; Director, GE Aerospace; Director, Merck Sharp & Dohme.
In numbers
- Trades disclosed
- 192
- Buys
- 2
- Sells
- 6
- Bought
- $89K
- Sold
- $1.8M
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 30 Dec 2005
- Last trade
- 12 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 15 Jun 2026 | OGN Organon & Cooption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $240K17,857.143 at $13.44 | filing |
| 12 Jun 2026filed 15 Jun 2026 | OGN Organon & Cooption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $240K17,857.14 at $13.44 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BX BlackstoneCapital Markets & Asset Management | SEC FORM 4 Code A | —1,961 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BX BlackstoneCapital Markets & Asset Management | SEC FORM 4 Code A | —1,961 at $0.00 | filing |
| 9 Jul 2025filed 10 Jul 2025 | BX BlackstoneCapital Markets & Asset Management | SEC FORM 4 Code A | —1,334 at $0.00 | filing |
| 13 Jun 2025filed 16 Jun 2025 | OGN Organon & Cooption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $240K23,904.38 at $10.04 | filing |
| 9 Jul 2024filed 10 Jul 2024 | BX BlackstoneCapital Markets & Asset Management | SEC FORM 4 Code A | —1,736 at $0.00 | filing |
| 7 Jun 2024filed 11 Jun 2024 | OGN Organon & Cooption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $200K9,638.55 at $20.75 | filing |
| 9 Jul 2023filed 11 Jul 2023 | BX BlackstoneCapital Markets & Asset Management | SEC FORM 4 Code A | —2,283 at $0.00 | filing |
| 9 Jun 2023filed 13 Jun 2023 | OGN Organon & Cooption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $200K10,086 at $19.83 | filing |
| 9 Jul 2022filed 11 Jul 2022 | BX BlackstoneCapital Markets & Asset Management | SEC FORM 4 Code A | —2,181 at $0.00 | filing |
| 10 Jun 2022filed 14 Jun 2022 | OGN Organon & Cooption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $200K5,640 at $35.46 | filing |
| 9 Jul 2021filed 13 Jul 2021 | BX BlackstoneCapital Markets & Asset Management | SEC FORM 4 Code A | —2,123 at $0.00 | filing |
| 4 Jun 2021filed 8 Jun 2021 | OGN Organon & Cooption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $316K8,772 at $36.05 | filing |
| 9 Jul 2020filed 13 Jul 2020 | BX BlackstoneCapital Markets & Asset Management | SEC FORM 4 Code A | —3,933 at $0.00 | filing |
| 31 Mar 2020filed 2 Apr 2020 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $30K389.91 at $76.94 | filing |
| 31 Dec 2019filed 3 Jan 2020 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $29K316.11 at $90.95 | filing |
| 30 Sep 2019filed 2 Oct 2019 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $29K341.53 at $84.18 | filing |
| 9 Jul 2019filed 11 Jul 2019 | BX BlackstoneCapital Markets & Asset Management | SEC FORM 4 Code A | —4,566 at $0.00 | filing |
| 28 Jun 2019filed 2 Jul 2019 | MRK Merck & Companyoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $29K342.87 at $83.85 | filing |
News
RTX Stock, GE Aerospace Ease Ahead Of Defense Earnings Amid Soaring DemandGE · investors.com · 19 Oct 2026Merck's 2.4% Dividend Yield: A Reliable Income Stream or a Risky Bet on Recovery?MRK · insidermonkey.com · 19 Oct 2026Uzbekistan, US-based GE Aerospace to expand aviation training cooperationGE · trend.az · 19 Oct 2026GE Aerospace (GE) Stock Price, News & AnalysisGE · 247wallst.com · 19 Oct 2026TD Waterhouse Canada Inc. Sells 23,156 Shares of Blackstone Inc. $BXBX · dailypolitical.com · 18 Oct 2026AbbVie vs. Merck: Which Pharma Stock Offers Better Value?MRK · insidermonkey.com · 16 Oct 2026Merck's Rally Reflects Renewed Confidence, but Has the Market Priced in Too Much?MRK · insidermonkey.com · 16 Oct 2026Blackstone (NYSE:BX) Given New $116.00 Price Target at UBS GroupBX · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Rochelle B. Lazarus; 9 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.